University of Virginia Health System Department of Pharmacy Services PGY2 Drug Information Residency Residency Purpose Statement

Transcription

1 University of Virginia Health System Department of Pharmacy Services PGY2 Drug Information Residency Residency Purpose Statement Pharmacists completing this program will be equipped with the skills and knowledge to obtain entry-level positions in drug information/ medication use policy in hospitals, health systems, academia, industry, managed care and medical writing. They are experts in analysis of medication-related information, possess superior communication skills, and are proficient in educating other health care professionals and healthcare professionals in training. They are prepared to serve as organization leaders in development of safe and effective medication-use policies and/or processes.

2 UNIVERSITY OF VIRGINIA HEALTH SYSM P.O. Box Charlottesville, VA Director of Pharmacy: Program Director: Contact Person: Rafael Saenz, Pharm.D., MD, FASHP (434) Michelle W. McCarthy, Pharm.D., FASHP (434) mm4tminia.edu Michelle W. McCarthy, Pharm.D., FASHP (434) RESIDENCY PROGRAM Type/Duration: 12 month/full-time residency Number of Positions: 1 Application Deadline: Received by January 3 Starting Date: July 1 Estimated Stipend: $49,250 Interview Required: Yes Special Features: This specialized residency is designed to provide intensive training in all aspects of drug information practice including literature retrieval and evaluation, formulary management, P&T Committee support, policy and procedure development, newsletter publication, medication safety, medication-use evaluation and adverse drug reaction program management, medical writing and investigational drugs. The resident will also be involved in experiential education of Pharm.D. students and PGY1-pharmacy residents. Elective rotations are tailored to meet the resident's needs and include a variety of clinical specialties, industry-based drug information practice, and poison control. Fringe Benefits: Health, dental, and liability insurance, 12 vacation days, 14 days sick leave, 8 holidays, educational and travel allowances. Special Requirements for Acceptance: Pharm.D. degree, completion of PGY1 residency, eligibility for Virginia licensure, letter of intent, college transcript, curriculum vitae, 2 technical writing samples, and 4 references. TRAINING SI Type: Hospital Owner/Affiliate: State Model Type: Teaching Professional Staff: 80 Non-Professional Staff: 80 Total Beds: 600 Average Daily Census: 550 Special Features: Comprehensive pharmacy services are supported by decentralized clinical pharmacy teams, state of the art automation/ technology and IV clean room, an electronic medical record, bar code medication administration, and computerized prescriber order entry. The University of Virginia Health System is a regional teaching and referral center offering a broad range of specialty services and supporting nationally recognized schools of medicine and nursing.

3 University of Virginia Health System Department of Pharmacy Services PGY2- Drug Information Residency Program Overview Program Structure The residency begins on July 1, 2014 and ends on Friday, 30, Residency rotations are 3-6 weeks in duration. Required rotations include: drug information orientation, medication safety, publishing/ editing, investigational drug service, medication use policy 1, 2 and 3 and supply chain/operations/informatics. Research Activities a. Completion of a major research project is a requirement of the residency. Final reports must be submitted in manuscript style acceptable for submission to a peer-reviewed biomedical journal and formally approved by all project preceptors. b. During the first half of the year, each resident will complete a medication use evaluation (MUE) on a selected therapeutic agent(s). Completed projects will be submitted for poster presentation at the University HealthSystem Consortium meeting held in conjunction with the ASHP Midyear Clinical Meeting. Results of the MUE are written up in a manner consistent with a manuscript for submission to a peer-reviewed biomedical journal and are presented to the Pharmacy and Therapeutics (P&T) Committee or appropriate P&T Work Group. Professional Leave for Meeting Attendance a. Residents will attend the ASHP Annual Midyear Clinical Meeting and an additional practice area specific meeting. A flat travel stipend is provided; expenses incurred beyond the stipend are the responsibility of the resident. Presentation Requirements a. The resident is required to provide a poster presentation on the results of his/her residency research project at the UVa Department of Medicine Scholars/ Research Day or other comparable scientific meeting b. Each resident is responsible for presenting one seminar and two case conferences during the course of the residency year. The Seminar is ACPE-accredited to provide continuing pharmaceutical education to pharmacists. To obtain CE credit, the presentations must have appropriate, measurable learning objectives, posttest questions that correlate with the learning objectives, and some component of audience participation/ active learning. c. The resident will also provide presentations to various healthcare professionals and healthcare professionals in training. Service a. Residents work in a supervisory function within the inpatient pharmacy for 16 hours every third weekend. b. Beginning in 2015, residents will also work 4 hours in the evenings every 2 weeks and one major holiday and its associated weekend (Thanksgiving and the day after, Christmas Eve and Christmas Day, or New Year s Eve and New Year s Day) during the year. Benefits Vacation/ Interview days/ Holidays a. Each resident receives 10 days to be used for personal leave or vacation. In order to avoid conflicts with rotation training experiences, the maximum amount of time off permitted in a rotation is 5 days. Vacation may not be used for terminal leave. All residents are expected to be at work during the last week of the residency. b. Each resident also receives up to 5 days to be used for interviews. c. Residents are provided up to 14 calendar days for sick leave. If there are additional sick days, vacation days must be used. Those sick for 2 or more consecutive days must present a physician s note to the Program Director/ Coordinator. In the case of extended illness or disability, please refer to the Leave or Request for Absence Policy. The applicable preceptor, program director, program coordinator, and weekend supervisor must be notified of illness.

4 d. All leave requests must be approved by the applicable preceptor, program director, and program coordinator and documented in the resident leave database. e. Residents also have the following holidays: Independence Day, Labor Day, Thanksgiving and the day after, Christmas Eve, Christmas Day and the day after, New Year s Eve, New Year s Day, and Memorial Day. However, the exception is the holidays that fall during weekends where residents are assigned to work. Certification a. Residents are required to obtain the Certificate in Public Health Sciences for Resident and Fellow Physicians. ( Advisors a. The resident is matched with an advisor for the duration of the residency year. The advisor may be any of the DI Residency preceptors. Matches are organized by the program director and are based on the career goals, specialty practice area interests, or other interests of the resident. Advisors serve as resources and mentors to the residents. b. The resident will also have a primary preceptor for each required presentations as well as the MUE and residency project. Residents and the program director identify appropriate preceptors for these requirements based on the topic.

5 University of Virginia Health System Department of Pharmacy Services PGY2 Drug Information Residency Residency Outcomes, Goals and Objectives Outcome R1: Demonstrate excellence in the provision of education, training, and evidence-based 1 information for health care professionals and health care professionals in training. Goal R1.1 Provide effective education and training on medication-use or drug therapy topics to health care professionals and health care professionals in training. OBJ R1.1.1 (Application) Use effective educational techniques in the design of all educational activities. OBJ R1.1.2 (Synthesis) Design an assessment strategy that appropriately measures the specified objectives for education or training and fits the learning situation. OBJ R1.1.3 (Application) Use skill in the four preceptor roles employed in practice-based teaching (direct instruction, modeling, coaching, and facilitation). OBJ R1.1.4 (Application) Use advanced public speaking skills to communicate effectively in large and small group situations. OBJ R1.1.5 (Synthesis) Exercise skill in leading a small group discussion that focuses on the evaluation of a piece of biomedical literature. Goal R1.2 Employ advanced literature analysis skills to analyze and effectively communicate evidence-based information. OBJ R1.2.1 (Synthesis) Create an efficient and effective advanced search strategy to obtain information. OBJ R1.2.2 (Analysis) Accurately identify the study design employed for a piece of biomedical literature. OBJ R1.2.3 (Evaluation) Determine if the study s design and methodology are appropriate to accomplish the objectives of a piece of biomedical literature. OBJ R1.2.4 (Evaluation) Accurately interpret statistical information presented in a piece of biomedical literature. OBJ R1.2.5 (Analysis) Identify potential sources of bias in a piece of biomedical literature. OBJ R1.2.6 (Evaluation) Determine the internal and external validity of a piece of biomedical literature. OBJ R1.2.7 (Evaluation) Determine if a study s results have applicability for hypothesizing future research or for directing patient care decisions. IO Explain how level of evidence is determined. OBJ R1.2.8 (Evaluation) When presented with conflicting biomedical literature, determine the validity and applicability for a specific information need. OBJ R1.2.9 (Evaluation) When presented with limited evidence-based biomedical literature, synthesize a reasonable response for the specific information need. OBJ R (Evaluation) Appraise information provided by a pharmaceutical manufacturer. OBJ R (Synthesis) Prepare an expert response to a complex information need. Goal R1.3 Contribute to the biomedical literature. OBJ R1.3.1 (Synthesis) Write a piece of literature (e.g., research article, review, letter to the editor, case report) that is suitable for publication. OBJ R1.3.2 (Application) Follow the submission requirements of an appropriate peer-reviewed publication to submit a manuscript for publication. OBJ R1.3.3 (Evaluation) Perform peer review of an article submitted for publication or presentation by a pharmacist. Goal R1.4 Prepare and deliver effective poster presentations.

6 OBJ R1.4.1 (Synthesis) Design an effective poster for the presentation of a specific topic. OBJ R1.4.2 (Synthesis) Exercise skill in responding to questions occurring during the presentation of a poster. Goal R1.5 Create pertinent, evidence-based medication information for health care professionals. OBJ R1.5.1 (Synthesis) Write evidence-based medication information for health care professionals using appropriate grammar, punctuation, and style. OBJ R1.5.2 (Evaluation) Edit medication information prepared by others. OBJ R1.5.3 (Synthesis) Provide constructive feedback to authors of materials one has edited. OBJ R1.5.4 (Analysis) Determine the appropriate venue for distribution of a specific piece of evidence-based medication information. Outcome R2: Contribute to the management of the organization s medication-use policies or processes. Goal R2.1 Enhance the quality of committee decisions on medication-use policies or processes. OBJ R2.1.1 (Synthesis) Plan a meeting that reflects the organization s needs and the political situation. OBJ R2.1.2 (Synthesis) Prepare evidence-based information for committee decisions on a medication-use policy or process, based on an analysis of the committee s needs. OBJ R2.1.3 (Analysis) Conduct a pharmacoeconomic analysis to support a medication policy and/or process recommendation or decision. OBJ R2.1.4 (Synthesis) Contribute the drug information specialist s perspective, as appropriate, in meetings about a medication-use policy and/or process. OBJ R2.1.5 (Synthesis) Prepare accurate and effective meeting minutes that satisfy the requirements of organizational, regulatory, and accreditation considerations, as applicable. OBJ R2.1.6 (Synthesis) Design a systematic follow-up that assesses the implementation and outcome of a change to a medication-use policy or process. Goal R2.2 Identify opportunities for improvement in the organization s medication-use policies or processes. OBJ R2.2.1 (Comprehension) Compare and contrast the feasibility and effectiveness of the range of methods that can be used by the drug information specialist to identify opportunities for improvement in a medication-use policy or process. OBJ R2.2.2 (Evaluation) Identify opportunities for improvement in a medication-use policy or process based on the analysis of adverse drug events (ADEs). OBJ R2.2.3 (Evaluation) Identify opportunities for improvement in a medication-use policy or process based on the conduct of a medication-use project or a comparison with benchmarking data. OBJ R2.2.4 (Analysis) Identify emerging trends and issues in medication use external to an organization. OBJ R2.2.5 (Analysis) If applicable, identify emerging trends and issues in medication use within one s organization. Goal R2.3 Develop and implement plans for improvements to the organization s medication-use process or policies. OBJ R2.3.1 (Synthesis) Design an intervention to change a problematic or potentially problematic aspect of a medication process or policy with the objective of improving quality. OBJ R2.3.2 (Synthesis) Collaborate with an interdisciplinary team to write or revise an existing guideline or protocol. OBJ R2.3.3 (Synthesis) Write or revise a medication-use policy or procedure with the objective of improving its quality. OBJ R2.3.4 (Synthesis) Implement an intervention to change a problematic or potentially problematic aspect of a medication policy or process with the objective of improving quality. OBJ R2.3.5 (Evaluation) Measure the impact of a change to a medication-use process or policy. Goal R2.4 Develop strategies for improving an organization s adverse drug event (ADE) monitoring and reporting program. OBJ R2.4.1 (Synthesis) Formulate strategies for improvement of the organization s ADE monitoring and reporting program. Outcome R3: Goal R3.1 Exercise leadership and practice management skills. Exhibit essential personal skills of a practice leader.

7 OBJ R3.1.1 (Characterization) Practice self-managed continuing professional development with the goal of improving the quality of one s own performance through self-assessment and personal change. OBJ R3.1.2 (Characterization) Demonstrate commitment to the profession of pharmacy through active participation in local, state, and/or national pharmacy professional organizations. OBJ R3.1.3 (Comprehension) Explain the nature of mentoring in pharmacy, its potential connection with achievement, and the importance of willingness to serve as mentor to appropriate individuals. OBJ R3.1.4 (Comprehension) Explain the general processes of establishing and maintaining an ASHP-accredited residency program. OBJ R3.1.5 (Comprehension) Explain the importance of contributing to the advancement of the profession through presentations and publications. OBJ R3.1.6 (Application) Use time management skills effectively to fulfill practice responsibilities. OBJ R3.1.7 (Characterization) Use sound ethical reasoning to guide practice decisions. OBJ R3.1.8 (Analysis) Identify potential conflict-of-interest situations in one s practice. OBJ R3.1.9 (Comprehension) When applicable, explain the intricacies of all regulatory and accreditation requirements that affect the medication-use policies or processes of the organization. Goal R3.2 Exercise superior communications skills. OBJ R3.2.1 (Application) Use effective negotiation skills to resolve conflicts. OBJ R3.2.2 (Characterization) Demonstrate a commitment to advocacy for optimal care of patients through the assertive and persuasive presentation of patient care issues to members of the organizational leadership, health care team, the patient, and/or the patient s caregivers. OBJ R3.2.3 (Application) Use group participation skills when leading, facilitating, or working as a member of an interdisciplinary committee or informal work group. OBJ R3.2.4 (Synthesis) Develop strategies for dealing with challenging communications situations. OBJ R3.2.5 (Analysis) Determine the appropriate type of communication, and the medium and organization for it, using an understanding of the target audience, the characteristics of the information to be communicated, effectiveness, efficiency, customary practice and the recipient's preferences. OBJ R3.2.6 (Application) Use listening skills effectively in performing job functions. Goal R3.3 Demonstrate political skills necessary to improve the organization s medication-use process or policies. OBJ R3.3.1 (Analysis) When confronted with a barrier to the accomplishment of a particular project, analyze the organizational environment, including its structure, network of resources, and politics, to determine a strategy for achieving success. OBJ R3.3.2 (Synthesis) Create an effective professional network. OBJ R3.3.3 (Analysis) Identify the organization s committees where pharmacist participation is essential. Outcome R4: Conduct drug information practice-related projects. Goal R4.1 Conduct a drug information practice-related project using effective project management skills. OBJ R4.1.1 (Synthesis) Identify a topic of significance for a drug information practice-related project. OBJ R4.1.2 (Synthesis) Formulate a feasible design for a drug information practice-related project. OBJ R4.1.3 (Synthesis) Secure any necessary approvals, including investigational review board approval, for one s design of a project. OBJ R4.1.4 Secure any necessary funding for one s project. OBJ R4.1.5 (Synthesis) Conduct a drug information practice-related project as specified in its design. OBJ R4.1.6 (Synthesis) Effectively present the results of a drug information practice-related project. OBJ R4.1.7 (Synthesis) Successfully employ an accepted manuscript style to prepare a final report of a drug information practice-related project. OBJ R4.1.8 (Evaluation) Accurately assess the impact, including sustainability if applicable, of the residency project. Outcome R5: Contribute to the management of the organization s budget. Goal R5.1 Provide drug cost forecasting. OBJ R5.1.1 (Analysis) Estimate the future cost implications for the organization of a new pharmaceutical agent.

8 OBJ R5.1.2 (Analysis) Estimate the future cost implications for the organization from patent expiration. OBJ R5.1.3 (Comprehension) Explain the organization s overall drug costs. Goal R5.2 Understand organizational decision-making for contracting for pharmaceuticals. OBJ R5.2.1 (Comprehension) Explain the organization s process for negotiating contracts for pharmaceuticals. Outcome E1: Contribute to the management of the organization s medication-use process. Goal E1.1 Contribute to efforts to prevent and identify risk points in the medication-use process. OBJ E1.1.1 (Evaluation) Participate in a proactive risk assessment, such as a failure mode and effects analysis (FMEA) or the Six Sigma methodology to define, measure, analyze, improve, and control (DMAIC). OBJ E1.1.2 (Comprehension) Explain the steps and applicability of a root cause analysis (RCA). Goal E1.2 Represent the pharmacy perspective to the organization s design and application of its technology and automation systems. OBJ E1.2.1 (Comprehension) Explain how to maintain effective liaisons between the pharmacy and information technology staff and other health care disciplines to support medication use. OBJ E1.2.2 (Synthesis) In collaboration with information technology professionals, physicians, nurses, pharmacists, and other pertinent health care providers, define patient information and medication information required by the organization s information system to support effective medication-related patient-care decisions by physicians, nurses, pharmacists, and other pertinent health care providers. OBJ E1.2.3 (Synthesis) Collaborate with physicians, nurses, pharmacists, and other pertinent health care providers to standardize the organization s processes for the communication of medication orders so that the risk of errors is minimized. OBJ E1.2.4 (Application) Participate in coordinating the inclusion of new formulary and medicationuse information into the organization s technology and automation systems. Goal E1.3 Collaborate with others in the organization to assure the availability of appropriate evidence-based medication information for the organization s health care providers. OBJ E1.3.1 (Synthesis) Formulate or make improvements to an existing plan that assures the availability of complete, current, evidence-based medication information resources in the pharmacy and in all patient-care areas where medications are prescribed and/or administered. Outcome E2: Contribute to the management of a drug information center/service. Goal E2.1 Contribute to the management of a drug information center/service. OBJ E2.1.1 (Comprehension) Explain the components of a proposal for the addition of services or resources to an existing drug information center/service. OBJ E2.1.2 (Synthesis) Devise strategies for fiscally sound management of a drug information center/service. OBJ E2.1.3 (Synthesis) Devise strategies for managing the human resources of a drug information center/service that result in an pleasant, effective and efficient working environment. OBJ E2.1.4 (Evaluation) Continually reassess the drug information needs of the organization. OBJ E2.1.5 (Synthesis) Use documented information on services provided by the drug information center/service to generate reports that describe the center s/service s productivity, quality, and outcomes. OBJ E2.1.6 (Evaluation) Appraise a drug information center s/service s continuous quality improvement program for effectiveness. OBJ E2.1.7 (Synthesis) Design improvements in a drug information center/service. Goal E2.2 Formulate the budget for a drug information center/service. OBJ E2.2.1 (Comprehension) Explain how to formulate a capital budget for a drug information center/service. OBJ E2.2.2 (Comprehension) Explain how to formulate a personnel budget for a drug information center/service. OBJ E2.2.3 (Comprehension) Explain how to formulate an operating budget for a drug information center/service.

9 OBJ E2.2.4 (Comprehension) Explain how to formulate a revenue budget for a drug information center/service. Outcome E4: Participate in the provision of drug study services. Goal E4.1 Manage the use of study drugs according to established protocols and the organization s policies and procedures. OBJ E4.1.1 (Application) Utilize appropriate procedures in storing study drugs. OBJ E4.1.2 (Application) Utilize appropriate procedures in dispensing study drugs. OBJ E4.1.3 (Application) Utilize appropriate procedures in documenting actions taken with study drugs. OBJ E4.1.4 (Application) Utilize appropriate procedures for initiation of a drug study. OBJ E4.1.5 (Evaluation) Critique a protocol and patient consent according to conventions established by the organization s institutional review board. OBJ E4.1.6 (Comprehension) Explain the process for reporting adverse drug events that occur during a drug study. Custom Goals and Objectives Goal: Manage the medication distribution process in all locations within the hospital where drugs reside. OBJ: (Evaluation) Based on one s own assessment of the pharmacy s drug control systems, contribute any needed recommendations for improvement. Goal: Understand how to assure pharmacy compliance with legal, regulatory, safety, and accreditation requirements. OBJ R2.4.1: (Comprehension) Explain the components of a departmental system that would assure compliance with applicable legal, regulatory, safety, and accreditation requirements

10 Required outcomes and educational goals for PGY2 Drug Information Residency DI Service Orientation Med Safety MUP1 MUP2 MUP3 Publishing/ Editing SC/ IT/ Ops Seminars Projects Outcome R1: Demonstrate excellence in the provision of education, training, and evidence-based 2 information for health care professionals and health care professionals in training.. Goal R1.1 Provide effective education and training on medication-use or drug therapy topics to health care professionals and health care professionals in training. OBJ R1.1.1 Use effective educational techniques in the design of all educational activities. OBJ R1.1.2 Design an assessment strategy that appropriately measures the specified objectives for education or training and fits the learning situation. OBJ R1.1.3 Use skill in the four preceptor roles employed in practice-based teaching (direct instruction, modeling, coaching, and facilitation). OBJ R1.1.4 Use advanced public speaking skills to communicate effectively in large and small group situations. OBJ R1.1.5 Exercise skill in leading a small group discussion that focuses on the evaluation of a piece of biomedical literature. Goal R1.2 Employ advanced literature analysis skills to analyze and effectively communicate evidence-based information. OBJ R1.2.1 Create an efficient and effective advanced search strategy to obtain information. OBJ R1.2.2 Accurately identify the study design employed for a piece of biomedical literature OBJ R1.2.3 Determine if the study s design and methodology are appropriate to accomplish the objectives of a piece of biomedical literature OBJ R1.2.4 Accurately interpret statistical information presented in a piece of biomedical literature. OBJ R1.2.5 Identify potential sources of bias

11 OBJ R1.2.6 OBJ R1.2.7 OBJ R1.2.8 OBJ R1.2.9 OBJ R OBJ R Goal R1.3 OBJ R1.3.1 OBJ R1.3.2 OBJ R1.3.3 Goal R1.4 OBJ R1.4.1 OBJ R1.4.2 DI Service Orientation in a piece of biomedical literature. Determine the internal and external validity of a piece of biomedical literature. Determine if a study s results have applicability for hypothesizing future research or for directing patient care decisions When presented with conflicting biomedical literature, determine the validity and applicability for a specific information need When presented with limited evidence-based biomedical literature, synthesize a reasonable response for the specific information need. Appraise information provided by a pharmaceutical manufacturer. Prepare an expert response to a complex information need. Contribute to the biomedical literature. Write a piece of literature (e.g., research article, review, letter to the editor, case report) that is suitable for publication. Follow the submission requirements of an appropriate peer-reviewed publication to submit a manuscript for publication. Perform peer review of an article submitted for publication or presentation by a pharmacist. Prepare and deliver effective poster presentations. Design an effective poster for the presentation of a specific topic. Exercise skill in responding to questions occurring during the presentation of a poster. Med Safety MUP1 MUP2 MUP3 Publishing/ Editing SC/ IT/ Ops Seminars Projects -MUE -project -MUE -project

12 DI Service Orientation Med Safety MUP1 MUP2 MUP3 Publishing/ Editing Goal R1.5 Create pertinent, evidence-based medication information for health care professionals. OBJ R1.5.1 Write evidence-based medication information for health care professionals using appropriate grammar, punctuation, and style. OBJ R1.5.2 Edit medication information prepared by others. OBJ R1.5.3 Provide constructive feedback to authors of materials one has edited. OBJ R1.5.4 Determine the appropriate venue for distribution of a specific piece of evidence-based medication information Outcome R2: Contribute to the management of the organization s medication-use policies or processes. Goal R2.1 Enhance the quality of committee decisions on medication-use policies or processes OBJ R2.1.1 Plan a meeting that reflects the organization s needs and the political situation OBJ R2.1.2 Prepare evidence-based information for committee decisions on a medication-use policy or process, based on an analysis of the committee s needs. OBJ R2.1.3 Conduct a pharmacoeconomic analysis to support a medication policy and/or process recommendation or decision. OBJ R2.1.4 Contribute the drug information specialist s perspective, as appropriate, in meetings about a medication-use policy and/or process. OBJ R2.1.5 Prepare accurate and effective meeting minutes that satisfy the requirements of organizational, regulatory, and accreditation considerations, as applicable. OBJ R2.1.6 Design a systematic follow-up that assesses the implementation and outcome of a change to a medication-use policy or process. SC/ IT/ Ops Seminars Projects -MUE

13 DI Service Orientation Med Safety MUP1 MUP2 MUP3 Publishing/ Editing SC/ IT/ Ops Seminars Projects Goal R2.2 OBJ R2.2.1 OBJ R2.2.2 OBJ R2.2.3 OBJ R2.2.4 OBJ R2.2.5 Goal R2.3 OBJ R2.3.1 OBJ R2.3.2 OBJ R2.3.3 OBJ R2.3.4 Identify opportunities for improvement in the organization s medication-use policies or processes. Compare and contrast the feasibility and effectiveness of the range of methods that can be used by the drug information specialist to identify opportunities for improvement in a medication-use policy or process. Identify opportunities for improvement in a medicationuse policy or process based on the analysis of adverse drug events (ADEs) Identify opportunities for improvement in a medicationuse policy or process based on the conduct of a medication-use project or a comparison with benchmarking data. Identify emerging trends and issues in medication use external to an organization. If applicable, identify emerging trends and issues in medication use within one s organization. Develop and implement plans for improvements to the organization s medication-use process Design an intervention to change a problematic or potentially problematic aspect of a medication process or policy with the objective of improving quality Collaborate with an interdisciplinary team to write or revise an existing guideline or protocol. Write or revise a medication-use policy or procedure with the objective of improving its quality. Implement an intervention to change a problematic or potentially problematic aspect -MUE -MUE -MUE -MUE -MUE -MUE

14 OBJ R2.3.5 of a medication policy or process with the objective of improving quality. Measure the impact of a change to a medication-use process or policy. DI Service Orientation Med Safety MUP1 MUP2 MUP3 Publishing/ Editing SC/ IT/ Ops Seminars Projects -MUE Goal R2.4 Develop strategies for improving an organization s adverse drug event (ADE) monitoring and reporting program. OBJ R2.4.1 Formulate strategies for improvement of the organization s ADE monitoring and reporting program. Outcome R3 Exercise leadership and practice management skills. Goal R3.1 Exhibit essential personal skills of a practice leader. OBJ R Practice self-managed continuing professional development with the goal of improving the quality of one s own performance through selfassessment and personal change. OBJ R3.1.2 Demonstrate commitment to the profession of pharmacy through active participation in local, state, and/or national pharmacy professional organizations OBJ R3.1.3 Explain the nature of mentoring in pharmacy, its potential connection with achievement, and the importance of willingness to serve as mentor to appropriate individuals. OBJ R3.1.4 Explain the general processes of establishing and maintaining an ASHP-accredited residency program. OBJ R3.1.5 Explain the importance of contributing to the advancement of the profession through presentations and publications. OBJ R3.1.6 Use time management skills effectively to fulfill practice -project -MUE responsibilities OBJ R3.1.7 Use sound ethical reasoning to guide practice decisions. OBJ R3.1.8 Identify potential conflict-of-

15 OBJ R3.1.9 Goal R3.2 OBJ R3.2.1 OBJ R3.2.2 OBJ R3.2.3 OBJ R3.2.4 OBJ R3.2.5 OBJ R3.2.6 Goal R3.4 OBJ R3.3.1 DI Service Orientation Med Safety MUP1 MUP2 MUP3 Publishing/ Editing interest situations in one s practice. When applicable, explain the intricacies of all regulatory and accreditation requirements that affect the medication-use policies or processes of the organization. Exercise superior communications skills. Use effective negotiation skills to resolve conflicts. Demonstrate a commitment to advocacy for optimal care of patients through the assertive and persuasive presentation of patient care issues to members of the organizational leadership, health care team, the patient, and/or the patient s caregivers. Use group participation skills when leading, facilitating, or working as a member of an interdisciplinary committee or informal work group. Develop strategies for dealing with challenging communications situations. Determine the appropriate type of communication, and the medium and organization for it, using an understanding of the target audience, the characteristics of the information to be communicated, effectiveness, efficiency, customary practice and the recipient's preferences. Use listening skills effectively in performing job functions. Demonstrate political skills necessary to improve the organization s medication-use process or policies When confronted with a barrier to the accomplishment of a particular project, analyze the organizational environment, including its structure, network SC/ IT/ Ops Seminars Projects

16 OBJ R3.3.2 OBJ R3.3.3 of resources, and politics, to determine a strategy for achieving success. Create an effective professional network. Identify the organization s committees where pharmacist participation is essential. DI Service Orientation Med Safety MUP1 MUP2 MUP3 Publishing/ Editing Outcome R4: Conduct drug information practice-related projects. Goal R4.1 Conduct a drug information practice-related project using effective project management skills. OBJ R4.1.1 Identify a topic of significance for a drug information practicerelated project OBJ R4.1.2 OBJ R4.1.3 OBJ R4.1.4 OBJ R4.1.5 OBJ R4.1.6 OBJ R4.1.7: OBJ R4.1.8 Formulate a feasible design for a drug information practicerelated project. Secure any necessary approvals, including investigational review board approval, for one s design of a project. Secure any necessary funding for one s project. Conduct a drug information practice-related project as specified in its design. Effectively present the results of a drug information practicerelated project.. Successfully employ an accepted manuscript style to prepare a final report of a drug information practice-related project. Accurately assess the impact, including sustainability if applicable, of the residency project. Outcome R5: Contribute to the management of the organization s budget. Goal R5.1 Provide drug cost forecasting. OBJ R5.1.1 Estimate the future cost implications for the organization of a new pharmaceutical agent. OBJ R5.1.2 Estimate the future cost implications for the SC/ IT/ Ops Seminars Projects -project -project -project -project -project -project -project -project

17 OBJ R5.1.3 Goal R5.2 OBJ R5.2.1 Outcome E1: Goal E.1 OBJ E1.1 OBJ E1.1.2 Goal E1.2 OBJ E1.2.4 DI Service Orientation Med Safety organization from patent expiration. Explain the organization s overall drug costs. Understand organizational decision-making for contracting for pharmaceuticals Explain the organization s process for negotiating contracts for pharmaceuticals. Contribute to the management of the organization s medication-use process. Contribute to efforts to prevent and identify risk points in the medication-use process Participate in a proactive risk assessment, such as a failure mode and effects analysis (FMEA) or the Six Sigma methodology to define, measure, analyze, improve, and control (DMAIC). Explain the steps and applicability of a root cause analysis (RCA). MUP1 MUP2 MUP3 Publishing/ Editing Represent the pharmacy perspective to the organization s design and application of its technology and automation systems. Participate in coordinating the inclusion of new formulary and medication-use information into the organization s technology and automation systems. SC/ IT/ Ops Seminars Projects Goal E1.3 Collaborate with others in the organization to assure the availability of appropriate evidence-based medication information for the organization s health care providers OBJ E1.3.1 Formulate or make improvements to an existing plan that assures the availability of complete, current, evidencebased medication information resources in the pharmacy and in all patient-care areas where medications are prescribed and/or administered Outcome E2 Contribute to the management of a drug information center/service. Goal E2.1 Contribute to the management of a drug information center/service. OBJ E2.1.1 Explain the components of a proposal for the addition of services or resources to an existing drug information

18 OBJ E2.1.2 OBJ E2.1.3 OBJ E2.1.4 OBJ E2.1.5 OBJ E2.1.6 OBJ E2.1.7 Goal E2.2 OBJ E2.2.1 OBJ E2.2.2 OBJ E2.2.3 Custom Goal Custom Goal DI Service Orientation Med Safety center/service Devise strategies for fiscally sound management of a drug information center/service. Devise strategies for managing the human resources of a drug information center/service that result in an pleasant, effective and efficient working environment. Continually reassess the drug information needs of the organization. Use documented information on services provided by the drug information center/service to generate reports that describe the center s/service s productivity, quality, and outcomes. Appraise a drug information center s/service s continuous quality improvement program for effectiveness. Design improvements in a drug information center/service. Formulate the budget for a drug information center/service. Explain how to formulate a capital budget for a drug information center/service Explain how to formulate a personnel budget for a drug information center/service. Explain how to formulate an operating budget for a drug information center/service. MUP1 MUP2 MUP3 Publishing/ Editing Manage the medication distribution process in all locations within the hospital where drugs reside. Based on one s own assessment of the pharmacy s drug control systems, contribute any needed recommendations for improvement. Understand how to assure pharmacy compliance with legal, regulatory, safety, and accreditation requirements. SC/ IT/ Ops Seminars Projects

19 Explain the components of a departmental system that would assure compliance with applicable legal, regulatory, safety, and accreditation requirements DI Service Orientation Med Safety MUP1 MUP2 MUP3 Publishing/ Editing Outcome E4: Participate in the provision of drug study services. E4.1 Manage the use of study drugs according to established protocols and the organization s policies and procedures OBJ E4.1.1 Utilize appropriate procedures in storing -IDS study drugs. OBJ E4.1.2 Utilize appropriate procedures in dispensing -IDS study drugs. OBJ E4.1.3 Utilize appropriate procedures in -IDS documenting actions taken with study drugs. OBJ E4.1.4 Utilize appropriate procedures for initiation -IDS of a drug study OBJ E4.1.5 Critique a protocol and patient consent according to conventions established by the organization s institutional review board. -IDS OBJ E4.1.6 Explain the process for reporting adverse drug events that occur during a drug study. -IDS SC/ IT/ Ops Seminars Projects Orientation and Weekend: Goal R1.2: Manage the medication distribution process in all locations within the hospital where drugs reside. OBJ R1.2.1: (Evaluation) Based on one s own assessment of the pharmacy s drug control systems, contribute any needed recommendations for improvement.

20 University of Virginia Health System Department of Pharmacy Services PGY2-Drug Information Residency Program Required Residency Rotations Orientation to DI Service/ Responding to DI Requests/ Information Retrieval o Always scheduled as Rotation 1 o Duration: 5 weeks Supply Chain/ Informatics/ Operations o Scheduled during first quarter o Duration 4-5 weeks Medication Use Policy #1 o Scheduled in the 1 st quarter o Duration: 4 weeks Publishing/ Editing o Scheduled in the 2 nd quarter of the year o Duration: 3-4 weeks during the holiday/ Midyear period Medication Use Policy #2 o Scheduled in the 2 nd or 3 rd quarters of the year o Duration: 5 weeks Investigational Drug Service o Scheduled in 2 nd or 3 rd quarters o Duration: 2-4 weeks Medication Safety o Scheduled in the 2 nd or 3 rd quarters of the year o Duration: 2 weeks, plus longitudinal Medication Use Policy #3 o Scheduled in the 3 rd or 4 th quarters of the year o Duration: 5 weeks Elective Opportunities Medication Safety Intensive- ISMP

21 Residency Preceptor Roster Preceptor Name Learning Experience Precepted Area of Day-to-Day Practice Amy Adams, Pharm.D. Investigational Drug Service Investigational Drug Service Scott Anderson, PharmD, MS Informatics Informatics Virginia Barton, R.Ph. Medication Safety Medication Safety Michael Bedenbaugh, PharmD, MBA, MS Susan Cogut, Pharm.D. Supply Chain DI Orientation Medication Use Policy (MUP) 1, 2, and 3 Publishing/ Editing Supply Chain Medication Use Policy Matt Jenkins, PharmD, MS Operations/ Staffing Operations Management Stephanie Mallow Corbett, Medication Safety PharmD, FCCM Michelle McCarthy, PharmD, FASHP MUP 1, 2, and 3 Publishing/ Editing Clinical Services Administration Safety and Quality Administration Medication Use Policy Stacey Pattie, PharmD, BCPS Emily Prabhu, PharmD, BCPS DI Orientation MUP 1, 2, and 3 DI Orientation MUP 1, 2, and 3 Medication Use Policy Medication Use Policy